NEWS ABOUT US EXPERIENCE STRATEGY TEAM PORTFOLIO CONTACT US

 

NEWS

2014 | 2012 | 2011 | 2010 | 2009

 

 

 


Amicus Therapeutics
December 30, 2013 - Amicus Therapeutics Completes Debt Financing of Up to $25 Million -- Follows $15 Million Equity Financing
Press Release | Company News


Kythera
December 19, 2013 - KKYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index
Press Release | Company News


Portola Pharmaceuticals
November 25, 2013 - Portola Pharmaceuticals Receives Breakthrough Therapy Designation From FDA for Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Antidote
Press Release | Company News


Alvine
October 29, 2013 - Alvine Pharmaceuticals Doses First Patient in Phase 2B Trial for ALV003 in Celiac Disease
Press Release | Company News


Portola Pharmaceuticals
October 24, 2013 - Portola Pharmaceuticals Announces Enrollment Has Begun in Phase 1/2 Study of PRT2070, an Oral Dual Syk/JAK Inhibitor for Genetically-Defined Hematologic Cancers
Press Release | Company News


Portola Pharmaceuticals
October 9, 2013 - Portola Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Study of PRT2070
Press Release | Company News


Kythera
October 8, 2013 - Kythera Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
Press Release | Company News


Baxano Surgical
October 1, 2013 - Baxano Surgical Announces the Launch of iO-Tome(TM), A Novel Minimally Invasive Facetectomy Instrument
Press Release | Company News


Kythera
September 16, 2013 - Kythera Shares Rise on Positive Phase III Results
Article | Company News


Kythera
September 16, 2013 - Kythera Announces Positive ATX-101 Top Line Phase III Trial Results for the Reduction of Submental Fat
Press Release | Company News


DFine
September 12, 2013 - DFine, Inc. receives CE Mark approval for the STAR™ Tumor Ablation System for treatment of painful metastatic spinal tumors
Press Release | Company News


DFine
September 9, 2013 - DFine Hires Greg Barrett As New President and CEO Former BARRX President and CEO Brings Extensive Operations and Commercial Experience to Fast Growing Spine Therapy Company
Press Release | Company News


Nora Therapeutics
July 30, 2013 - Nora Therapeutics, Inc. initiates Thrive-IVF Research Study to help improve pregnancy success rates and outcomes in women with a history of repeated in vitro fertilization (IVF) failures
Press Release | Company News


NGM Biopharmaceuticals
July 18, 2013 - NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity
Press Release | Company News


Portola Pharmaceuticals
July 2, 2013 - Portola Announces Positive Phase 2 Study Results Showing Factor Xa Inhibitor Antidote PRT4445 Reverses Anticoagulant Activity of Eliquis(R)
Press Release | Company News


NGM Biopharmaceuticals
June 17, 2013 - NGM Biopharmaceuticals and MedImmune, AstraZeneca’s Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
Press Release | Company News


Topica Pharmaceuticals
June 12, 2013- Topica announces completion of enrollment in its phase 2B/3 Onychomycosis Trial of 10% Luliconazole Solution
Press Release | Company News


Portola Pharmaceuticals
May 22, 2013 - Portola announces pricing of initial public offering
Press Release | Company News


NinePoint
May 16, 2013 - NinePoint Medical Announces U.S. Commercial Availability of the NvisionVLE™ Imaging System
Press Release | Company News


Alvine
May 14, 2013 - AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Press Release | Company News


NinePoint
April 26, 2013 - NinePoint Medical Receives Additional FDA 510(k) Clearance for NvisionVLE Imaging System
Press Release | Company News


Baxano Surgical
February 19, 2013 - Baxano Announces Milestone in Clinical Use of iO-Flex® Technology
Press Release | Company News


Portola Pharmaceuticals
February 5, 2013 - Portola Enters Clinical Collaboration Agreement with Bayer and Janssen for Phase 2 Study of PRT4445 and XARELTO
Press Release | Company News


DFine
January 29, 2013 - DFine Announces the launch of StabiliT® ERX, the latest advancement in family of energy-responsive, ultra-high viscosity bone cements
Press Release | Company News


Portola Pharmaceuticals
January 29, 2013 - Portola and Lee’s Pharmaceutical Enter into Agreement to Expand Phase 3 APEX Study of Betrixaban into China
Press Release | Company News


DFine
January 8, 2013 - DFine announces exclusive distribution agreement with Biomet
Press Release | Company News


NGM Biopharmaceuticals
January 3, 2013 - NGM Enters Agreement With Janssen to Discover and Develop Novel Therapeutics for Diabetes
Press Release | Company News

 

News Archives